FTSE 100
|
9 216,67
|
-11,44
|
-0,12 %
|
Analysen zu FTSE 100-Werten
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | HSBC Holdings Overweight | Barclays Capital | |
| 02.02.24 | Shell Outperform | RBC Capital Markets | |
| 02.02.24 | easyJet Overweight | Barclays Capital | |
| 02.02.24 | Reckitt Benckiser Buy | UBS AG | |
| 01.02.24 | Shell Buy | Jefferies & Company Inc. | |
| 01.02.24 | Diageo Underperform | RBC Capital Markets | |
| 01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 01.02.24 | Shell Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Glencore Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Outperform | RBC Capital Markets | |
| 01.02.24 | Shell Neutral | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | easyJet Sector Perform | RBC Capital Markets | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research | |
| 31.01.24 | Diageo Sell | Deutsche Bank AG | |
| 31.01.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 31.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Hold | Jefferies & Company Inc. | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Diageo Overweight | Barclays Capital | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | Diageo Outperform | Bernstein Research | |
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Diageo Underperform | RBC Capital Markets | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | BAT Neutral | UBS AG |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 4 |
| Unilever | 2 |
| Diageo | 2 |
| GSK | 2 |
| easyJet | 1 |
| Rolls-Royce | 1 |
| BAT | 1 |
| Reckitt Benckiser | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.